Your browser doesn't support javascript.
loading
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
Capodanno, Davide; Mehran, Roxana; Krucoff, Mitchell W; Baber, Usman; Bhatt, Deepak L; Capranzano, Piera; Collet, Jean-Philippe; Cuisset, Thomas; De Luca, Giuseppe; De Luca, Leonardo; Farb, Andrew; Franchi, Francesco; Gibson, C Michael; Hahn, Joo-Yong; Hong, Myeong-Ki; James, Stefan; Kastrati, Adnan; Kimura, Takeshi; Lemos, Pedro A; Lopes, Renato D; Magee, Adrian; Matsumura, Ryosuke; Mochizuki, Shuichi; O'Donoghue, Michelle L; Pereira, Naveen L; Rao, Sunil V; Rollini, Fabiana; Shirai, Yuko; Sibbing, Dirk; Smits, Peter C; Steg, P Gabriel; Storey, Robert F; Ten Berg, Jurrien; Valgimigli, Marco; Vranckx, Pascal; Watanabe, Hirotoshi; Windecker, Stephan; Serruys, Patrick W; Yeh, Robert W; Morice, Marie-Claude; Angiolillo, Dominick J.
Affiliation
  • Capodanno D; Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco," University of Catania, Italy (D.C., P.C.).
  • Mehran R; Zena and Michael A. Wiener Cardiovascular Institute (R.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Krucoff MW; Duke University Medical Center, Durham, NC (M.W.K., R.D.L.).
  • Baber U; University of Oklahoma Health Sciences Center, Oklahoma City (U.B.).
  • Bhatt DL; Mount Sinai Heart (D.L.B.), Icahn School of Medicine at Mount Sinai, New York, NY.
  • Capranzano P; Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco," University of Catania, Italy (D.C., P.C.).
  • Collet JP; Sorbonne Université, ACTION Study Group, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (APHP), Paris, France (J.-P.C.).
  • Cuisset T; Interventional Cardiology Unit and Cathlab, Department of Cardiology, University Hospital, La Timone, Marseille, France (T.C.).
  • De Luca G; Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "G Martino," University of Messina, Italy (G.D.L.).
  • De Luca L; Division of Cardiology, IRCCS Hospital Galeazzi-Sant'Ambrogio, Milan, Italy (G.D.L.).
  • Farb A; UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy (L.D.L.).
  • Franchi F; US Food and Drug Administration, Silver Spring, MD (A.F., A.M.).
  • Gibson CM; Division of Cardiology, University of Florida College of Medicine, Jacksonville (F.F., F.R., D.J.A.).
  • Hahn JY; Baim Institute for Clinical Research, Boston, MA (C.M.G.).
  • Hong MK; Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (J.-Y.H.).
  • James S; Division of Cardiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea (M.-K.H.).
  • Kastrati A; Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Sweden (S.J.).
  • Kimura T; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany (A.K.).
  • Lemos PA; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK; German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany (A.K., D.S.).
  • Lopes RD; Department of Cardiology, Hirakata Kohsai Hospital, Osaka, Japan (T.K.).
  • Magee A; Hospital Israelita Albert Einstein, São Paulo, Brazil (P.A.L.).
  • Matsumura R; Duke University Medical Center, Durham, NC (M.W.K., R.D.L.).
  • Mochizuki S; US Food and Drug Administration, Silver Spring, MD (A.F., A.M.).
  • O'Donoghue ML; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan (R.M., S.M., Y.S.).
  • Pereira NL; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan (R.M., S.M., Y.S.).
  • Rao SV; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O.).
  • Rollini F; Department of Cardiovascular Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN (N.L.P.).
  • Shirai Y; NYU Langone Health System, New York, NY (S.V.R.).
  • Sibbing D; Division of Cardiology, University of Florida College of Medicine, Jacksonville (F.F., F.R., D.J.A.).
  • Smits PC; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan (R.M., S.M., Y.S.).
  • Steg PG; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK; German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany (A.K., D.S.).
  • Storey RF; Ludwig-Maximilians University München, Munich, Germany (D.S.).
  • Ten Berg J; Privatklinik Lauterbacher Mühle am Ostsee, Seeshaupt, Germany (D.S.).
  • Valgimigli M; Department of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands (P.C.S.).
  • Vranckx P; Université Paris-Cité, AP-HP, Paris, France (P.G.S.).
  • Watanabe H; INSERM U-1148/LVTS, Paris, France (P.G.S.).
  • Windecker S; Institut Universitaire de France, Paris (P.G.S.).
  • Serruys PW; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, UK (R.F.S.).
  • Yeh RW; Cardiovascular Research Institute Maastricht (CARIM), School for Cardiovascular Diseases, Maastricht University Medical Center, the Netherlands (J.t.B.).
  • Morice MC; Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands (J.t.B.).
  • Angiolillo DJ; Department of Cardiology, University Medical Center Maastricht, the Netherlands (J.t.B.).
Circulation ; 147(25): 1933-1944, 2023 06 20.
Article in En | MEDLINE | ID: mdl-37335828

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Coronary Artery Disease / Acute Coronary Syndrome / Percutaneous Coronary Intervention Type of study: Etiology_studies Limits: Humans Language: En Journal: Circulation Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Coronary Artery Disease / Acute Coronary Syndrome / Percutaneous Coronary Intervention Type of study: Etiology_studies Limits: Humans Language: En Journal: Circulation Year: 2023 Document type: Article